There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

The winter vomiting bug affects millions of Britons every year, but a new vaccine could help reduce the massive impact of ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

It is hoped the new norovirus jab could help lift the burden on the NHS over the busy winter months - here we explain who is ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

The first, an investigational norovirus mRNA vaccine from Moderna (mRNA-1403), safely elicited strong antibody responses in ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...

CAMBRIDGE, MA – Moderna , Inc. (NASDAQ:MRNA) has initiated a Phase 3 clinical trial for its investigational norovirus vaccine, marking a significant step toward addressing the widespread public ...

At IDWeek 2024, Moderna presented interim results ... a prophylactic vaccine candidate under investigation for norovirus (NoV) infections. As one of the leading causes of acute gastroenteritis ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.